ArticleBiology direct2026
A novel TAp63γ-Airn regulatory axis governs early myogenic gene networks.
Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Skeletal muscle development relies on tightly coordinated transcriptional programs, yet the contribution of long non-coding RNAs (lncRNAs) to myogenesis remains largely unexplored. We previously demonstrated that the transcription factor TAp63γ is upregulated during myoblast differentiation and regulates the expression of genes involved in early stages of myogenic maturation. Here, combining transcriptome profiling with p63 ChIP-seq analysis in differentiating mouse myoblasts, we identify the lncRNA Airn as a direct transcriptional target of TAp63γ. Our findings position Airn as a previously unrecognized regulator of myogenic commitment that modulates both MyoD and MyoG expression at the mRNA and protein levels. Our work uncovers a novel TAp63γ-Airn axis essential for proper skeletal muscle differentiation and with potential relevance to muscle-wasting diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.